Atlas Trials

Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer

Clinical trial NCT00949052 · TERMINATED

Trial details

NCT number
NCT00949052
Sponsor
Vanderbilt-Ingram Cancer Center
Status
TERMINATED
Study type
OBSERVATIONAL
Cancer
Start date
2009-01-01
Primary completion
2014-12-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.